Heating of 5- and 7-chloro-6H-anthra[1,9-cd]pyrazol-6-ones in butylamine and aniline gives the corresponding peri-amino-substituted anthrapyrazole derivatives. Acylation of the latter occurs at the N-1 atom of the heterocyclic fragment to afford monoacyl derivatives having an ana-quinonimine structure.
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES
申请人:Electrophoretics Limited
公开号:US20160354375A1
公开(公告)日:2016-12-08
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
Gvon, Khan Ir; Shishkina, E. Yu.; Vorozhtsov, G. N., Doklady Chemistry, 1994, vol. 334, # 4-6, p. 40 - 43
作者:Gvon, Khan Ir、Shishkina, E. Yu.、Vorozhtsov, G. N.
DOI:——
日期:——
——
作者:N. T. Sokolyuk、L. P. Pisulina、A. I. V'yugin
DOI:10.1023/a:1015363010795
日期:——
Heating of 5- and 7-chloro-6H-anthra[1,9-cd]pyrazol-6-ones in butylamine and aniline gives the corresponding peri-amino-substituted anthrapyrazole derivatives. Acylation of the latter occurs at the N-1 atom of the heterocyclic fragment to afford monoacyl derivatives having an ana-quinonimine structure.